The most frequent drug-related AEs with ceftobiprole were diarrhea 6.2%, laboratory test abnormalities (5.2%), nausea and phlebitis 4.1% each, alanine aminotransferase increased, headache and vomiting in 3.1% each. This evidence concerns the gene GPT and phlebitis.